Bio-Techne Acquisitions

Bio-Techne has acquired 17 companies and its latest acquisition was Lunaphore Technologies SA on Jun 2023

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Lunaphore Technologies SA

Jun 2023

Source »
undisclosed
-
Namocell, Inc.

Jun 2022

Source »
undisclosed
Namocell is a California-based biotechnology company that provides solutions such as single cell genomics, cell line development, antibody discovery and synthetic biology.
Asuragen, Inc.

Mar 2021

Source »
$215M
Asuragen is a molecular diagnostic product company that provides oncology, and clinical testing services for cancer diagnosis.
B-MoGen Biotechnologies, Inc.

Jun 2019

Source »
undisclosed
B-MoGen provides gene editing solutions for immunotherapy treatments.
Quad Technologies, Inc.

Jun 2018

Source »
undisclosed
Quad is a developer and provider of cell separation and activation technology for cell and gene therapy applications.

Frequently Asked Questions about Bio-Techne

  1. What companies did Bio-Techne acquire?

    Companies acquired by Bio-Techne include Lunaphore, Namocell and Asuragen
  2. How many acquisitions does Bio-Techne have?

    Bio-Techne has acquired 17 companies including Lunaphore, Namocell and Asuragen.
  1. How many acquisitions did Bio-Techne make in 2023?

    In 2023 Bio-Techne acquired 1 companies including Lunaphore.